BCIM
BNR

British Columbia Investment Management’s Burning Rock Biotech BNR Stock Holding History

British Columbia Investment Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,820
Closed -$325K – 841
2021
Q3 		$325K Hold
1,820
– – ﹤0.01% 834
2021
Q2 		$536K Buy
+1,820
New +$538K ﹤0.01% 832

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

British Columbia Investment Management's BNR Position: Q4 2021 in Review

British Columbia Investment Management sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 1,820 shares — an estimated $325K sold.

British Columbia Investment Management first reported a position in BNR in Q2 2021 and held it in 2 quarters. The position peaked at $536K in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • British Columbia Investment Management reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • British Columbia Investment Management sold 1,820 Burning Rock Biotech shares in Q4 2021, an estimated $325K.
  • British Columbia Investment Management first reported a position in Burning Rock Biotech in Q2 2021 and held it in 2 quarters.
  • British Columbia Investment Management's Burning Rock Biotech position peaked at $536K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on British Columbia Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.